Peramivir Trihydrate is a synthetic neuraminidase inhibitor classified as an antiviral medication used for the treatment of seasonal influenza in patients who are unable to tolerate other antiviral therapies.… Read more
Peramivir Trihydrate is a synthetic neuraminidase inhibitor classified as an antiviral medication used for the treatment of seasonal influenza in patients who are unable to tolerate other antiviral therapies. By blocking the neuraminidase enzyme, this agent prevents the release of new viral particles from host cells, effectively inhibiting viral replication. To ensure accuracy in drug development and regulatory compliance, analytical laboratories rely on high-quality reference standards. This category provides access to Peramivir Trihydrate API, as well as its related impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for comprehensive impurity profiling, method development, and the rigorous quality control validation processes required to maintain pharmaceutical safety and efficacy standards throughout the lifecycle of the drug.